Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 22881
Gene Symbol: ANKRD6
ANKRD6
0.010 GeneticVariation group BEFREE Rare missense mutations in ANKRD6 could affect a balanced reciprocal antagonism between both Wnt pathways in neurulation and act as predisposing factors to NTDs in a subset of patients. 25200652 2015
Entrez Id: 311
Gene Symbol: ANXA11
ANXA11
0.010 Biomarker group BEFREE Among the identified VPA-responsive genes, some have been associated previously with NTDs or VPA effects [vinculin, metallothioneins 1 and 2 (Mt1, Mt2), keratin 1-18 (Krt1-18)], whereas others provide novel putative VPA targets, some of which are associated with processes relevant to neural tube formation and closure [transgelin 2 (Tagln2), thyroid hormone receptor interacting protein 6, galectin-1 (Lgals1), inhibitor of DNA binding 1 (Idb1), fatty acid synthase (Fasn), annexins A5 and A11 (Anxa5, Anxa11)], or with VPA effects or known molecular actions of VPA (Lgals1, Mt1, Mt2, Id1, Fasn, Anxa5, Anxa11, Krt1-18). 15345369 2004
Entrez Id: 308
Gene Symbol: ANXA5
ANXA5
0.010 Biomarker group BEFREE Among the identified VPA-responsive genes, some have been associated previously with NTDs or VPA effects [vinculin, metallothioneins 1 and 2 (Mt1, Mt2), keratin 1-18 (Krt1-18)], whereas others provide novel putative VPA targets, some of which are associated with processes relevant to neural tube formation and closure [transgelin 2 (Tagln2), thyroid hormone receptor interacting protein 6, galectin-1 (Lgals1), inhibitor of DNA binding 1 (Idb1), fatty acid synthase (Fasn), annexins A5 and A11 (Anxa5, Anxa11)], or with VPA effects or known molecular actions of VPA (Lgals1, Mt1, Mt2, Id1, Fasn, Anxa5, Anxa11, Krt1-18). 15345369 2004
Entrez Id: 317
Gene Symbol: APAF1
APAF1
0.010 Biomarker group BEFREE Key apoptotic genes APAF1 and CASP9 implicated in recurrent folate-resistant neural tube defects. 29358613 2018
Entrez Id: 338
Gene Symbol: APOB
APOB
0.010 AlteredExpression group BEFREE We found that the myristoylated alanine-rich C-kinase substrate, Kunitz-type protease inhibitor 2, and apolipoprotein B-100 protein levels were decreased in both embryos and the sera of pregnant Sprague-Dawley rats carrying embryos with NTDs. 28695418 2017
Entrez Id: 8289
Gene Symbol: ARID1A
ARID1A
0.010 GeneticVariation group BEFREE Of the secondary tests performed, ARID1A rs11247593 was associated with NTDs in whites, and ALDH1A2 rs7169289 was associated with isolated NTDs in African Americans. 25293959 2014
Entrez Id: 429
Gene Symbol: ASCL1
ASCL1
0.010 AlteredExpression group BEFREE We also report that p53S decreased expression of UTX at mRNA and protein level via increasing Xist transcript, result in high female-specific H3K27me3 expression and repressed Mash1 transcription, which facilitating abnormal proliferation, differentiation, and apoptosis, result in the mis-regulation of neurodevelopment and neural tube defects (NTDs). 31523200 2019
Entrez Id: 546
Gene Symbol: ATRX
ATRX
0.010 Biomarker group BEFREE Misexpression of ATRX was associated with growth retardation, neural tube defects and a high incidence of embryonic death. 11823444 2002
Entrez Id: 590
Gene Symbol: BCHE
BCHE
0.010 Biomarker group BEFREE Serum cholinesterase in the mothers of neural tube defect progeny. 7083614 1982
Entrez Id: 635
Gene Symbol: BHMT
BHMT
0.340 GeneticVariation group BEFREE The BHMT gene rs3733890, RFC1 gene rs1051266 and MTR gene rs1805087 were associated with the occurrence of NTDs in Han population of Northern China. 28770393 2018
Entrez Id: 635
Gene Symbol: BHMT
BHMT
0.340 GeneticVariation group BEFREE Since genetic deficiencies in folate-dependent homocysteine metabolism have been identified in NTD families, we investigated a common variant in betaine-homocysteine methyltransferase (BHMT), 742G-->A (R239Q), as a genetic modifier of NTD risk. 12749058 2003
Entrez Id: 635
Gene Symbol: BHMT
BHMT
0.340 GeneticVariation group BEFREE MTHM 501A>G only in case of GDM, and BHMT 716G>A only in case of no folate supplementation contribute to the etiology of NTDs. 24326202 2014
Entrez Id: 635
Gene Symbol: BHMT
BHMT
0.340 Biomarker group CTD_human In 304 Caucasian American NTD families with myelomeningocele or anencephaly, we examined 28 polymorphisms in 11 genes: folate receptor 1, folate receptor 2, solute carrier family 19 member 1, transcobalamin II, methylenetetrahydrofolate dehydrogenase 1, serine hydroxymethyl-transferase 1, 5,10-methylenetetrahydrofolate reductase (MTHFR), 5-methyltetrahydrofolate-homo-cysteine methyltransferase, 5-methyltetrahydrofolate-homocysteine methyltransferase reductase, betaine-homocysteine methyltransferase (BHMT), and cystathionine-beta-synthase. 17035141 2006
Entrez Id: 635
Gene Symbol: BHMT
BHMT
0.340 Biomarker group BEFREE We replicated the association of TCN2, BHMT and GLI3 with NTD risk in the 81 cases. 31139930 2019
Entrez Id: 649
Gene Symbol: BMP1
BMP1
0.100 GeneticVariation group BEFREE Knockout mice that are heterozygotes of single PCP genes likely fail to produce NTD phenotypes, yet damaging variants detected in human NTDs are almost always heterozygous, suggesting that other deleterious interacting variants are likely to be present. 29618362 2018
Entrez Id: 649
Gene Symbol: BMP1
BMP1
0.100 GeneticVariation group BEFREE In vertebrate embryos undergoing convergent extension (CE), the Planar Cell Polarity (PCP) pathway drives the elongation of the body axis and shapes the central nervous system, and mutations of the PCP genes predispose humans to various malformations including neural tube defects. 30579764 2019
Entrez Id: 649
Gene Symbol: BMP1
BMP1
0.100 GeneticVariation group BEFREE Additionally, glypicans function in the planar cell polarity (PCP) pathway, and several PCP genes have been associated with NTDs. 23223018 2013
Entrez Id: 649
Gene Symbol: BMP1
BMP1
0.100 Biomarker group BEFREE Here, we summarize our current understanding of how PCP factors affect the pathogenesis of NTDs. 21864354 2011
Entrez Id: 649
Gene Symbol: BMP1
BMP1
0.100 Biomarker group BEFREE Homozygous disruption of PCP genes in mice results in a spectrum of NTDs, including defects that affect the entire neural axis (craniorachischisis), cranial NTDs (exencephaly) and spina bifida. 21840926 2011
Entrez Id: 649
Gene Symbol: BMP1
BMP1
0.100 Biomarker group BEFREE Moreover, the Wnt/PCP-Jnk-dependent pathway plays an important role in taurine-mediated prevention of NTDs. 28718066 2017
Entrez Id: 649
Gene Symbol: BMP1
BMP1
0.100 Biomarker group BEFREE The Looptail (Lp) mutant mouse was the first mammalian mutant implicating a PCP gene (Vangl2) in the pathogenesis of NTD. 29063958 2018
Entrez Id: 649
Gene Symbol: BMP1
BMP1
0.100 Biomarker group BEFREE We suggest that other PCP genes should be considered as candidates for a role in the etiology of human NTDs. 19129707 2009
Entrez Id: 649
Gene Symbol: BMP1
BMP1
0.100 GeneticVariation group BEFREE These results demonstrate that PCP gene alterations contribute to the etiology of human NTDs. 24307374 2014
Entrez Id: 649
Gene Symbol: BMP1
BMP1
0.100 Biomarker group BEFREE Our study demonstrates that PRICKLE1 could act as a predisposing factor to human NTDs and further expands our knowledge of the role of PCP genes in the pathogenesis of these malformations. 21901791 2011
Entrez Id: 652
Gene Symbol: BMP4
BMP4
0.020 Biomarker group BEFREE Evaluation of BMP4 and its specific inhibitor NOG as candidates in human neural tube defects (NTDs). 12404109 2002